Overview
ELV market data
Price History
ELV price chart
Valuation & Profitability
- P/E (TTM)
- 17.42 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $25.21 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.72 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.7% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $274.84 – $436.24 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $86.5B · P/B 1.78 · P/S 0.43.
Company News
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFsBenzinga · Aug 14, 2026, 1:48 PM
Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’Benzinga · Aug 11, 2026, 8:28 AM
'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ ExclusiveBenzinga · Jul 28, 2026, 8:02 PM
Leerink Partners Maintains Market Perform on Elevance Health, Raises Price Target to $395Benzinga · Jul 17, 2026, 6:15 PM
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage LossesBenzinga · Jul 16, 2026, 5:24 PM
RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424Benzinga · Jul 16, 2026, 3:03 PM
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473Benzinga · Jul 16, 2026, 2:52 PM
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel ItBenzinga · Jul 16, 2026, 1:24 PM
These Analysts Revise Their Forecasts On Elevance Health Following Q2 EarningsBenzinga · Jul 16, 2026, 12:17 PM
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455Benzinga · Jul 16, 2026, 12:02 PM